Grant funding can be a catalyst for scientific and commercial progress. Adriann Sax, CEO & Co-Founder of Vetigenics, shares how strategic use of SBIR and foundation grants enabled the company to build a canine antibody platform, attract support from investors, and secure partners such as Merck Animal Health.
Session Topics:
Funding
Grant
Canine
Milestone - Platform Technology
Antibody
Speaker(s):
Adriann Sax
President & CEO
Vetigenics
Time:
5.40pm - 6.00pm
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)
Force Inline Description:
0